January 20, 2020   VASCULITIS   Frailty, CRP, Age Predict Death in ANCA Vasculitis Frailty score, age and C-reactive protein (CRP) are associated with mortality in elderly patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, say researchers writing in Rheumatology this fall. Learn more   FDA Approves First-Ever Treatment for Pediatric GPA, MPA The U.S. Food and Drug Administration has approved rituximab (Rituxan, Genentech) for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in children 2 years of age and older in combination with glucocorticoids, to fulfil an unmet medical need for these rare and serious diseases in children. Learn more   MORE FROM RHEUMATOLOGY NETWORK • EULAR Updates Guidelines for Large Vessel Vasculitis • Image IQ: Smooth Plaques With Pain and Itch • New Data Demonstrates Link Between Gout and Cardiovascular Disease • Diabetes and RA: Explaining the Similarities • Insulin Resistance Linked to Rheumatoid Arthritis Flares • 10 Notable Advances in Rheumatology from 2019   RHEUMATOLOGY HEALTHCARE JOB OPPORTUNITIES Visit Rheumatology Network for easy access to new job opportunities in rheumatology. As a service to our readers, we've posted a national "Job Board" in the upper right-hand corner of the site. Suggestions for other content sections? Email the editor at areyes@mmhgroup.com.